Hrt Financial LP Bellerophon Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.67 - $1.2 $18,783 - $33,642
28,035 New
28,035 $25,000
Q4 2021

Feb 14, 2022
SELL
$2.36 - $4.05 $28,034 - $48,109
-11,879 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.75 - $4.86 $7,241 - $9,384
-1,931 Reduced 13.98%
11,879 $48,000
Q2 2021

Aug 16, 2021
BUY
$3.83 - $5.65 $52,892 - $78,026
13,810 New
13,810 $66,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $382K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email